Cargando…
PLK1 as a cooperating partner for BCL2-mediated antiapoptotic program in leukemia
The deregulation of BCL2 family proteins plays a crucial role in leukemia development. Therefore, pharmacological inhibition of this family of proteins is becoming a prevalent treatment method. However, due to the emergence of primary and acquired resistance, efficacy is compromised in clinical or p...
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484999/ https://www.ncbi.nlm.nih.gov/pubmed/37679323 http://dx.doi.org/10.1038/s41408-023-00914-7 |